Cancer Related Major Depression Treated With a Single Dose of Psilocybin

Key facts

Sponsor

Section for Affective Disorders; Northern Stockholm Psychiatry

Principal Investigator

Johan Lundberg, MD PhD

Norra Stockholms Psykiatri and Karolinska Institutet

Intervention

psilocybin 25 mg sod(drug)

Enrollment

100 target

Eligibility

20-80 years · All sexes

Timeline

2024 – 2026

Study locations (4)

• region Västra Götaland, Gothenburg, Göteborg, Sweden
• Norra Stockholms Psykiatri, Stockholm, Stockholm County, Sweden
• Psykiatriska Kliniken, Akademiska Sjukhuset, Uppsala, Uppsala County, Sweden
• Örebro sjukhus, Örebro, Örebro County, Sweden

Collaborators

Uppsala University Hospital · Region Örebro County · Vastra Gotaland Region · Karolinska Institutet

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Mal de débarquement

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNANCT07579078
  Effect of Vitamin D Supplementation on Brain Waves in Female Major Depressive Disorder Patients With Hypovitaminosis D
  Bangladesh Medical University
• RECRUITINGNCT07377682
  Real-world Clinical Response to Trazodone in Italy, Poland, and Romania
  Aziende Chimiche Riunite Angelini Francesco S.p.A
• ACTIVE NOT RECRUITINGPHASE2NCT07458022
  MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER
  University of Child Health Sciences and Children's Hospital, Lahore
• RECRUITINGNCT07422844
  Dynamic Network Response to TMS Treatment
  Goethe University
• RECRUITINGNANCT07316803
  Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness
  Centre hospitalier de Ville-Evrard, France
• RECRUITINGNCT07258485
  A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)
  Janssen Research & Development, LLC
• RECRUITINGNANCT07009223
  Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
  IRCCS Centro San Giovanni di Dio Fatebenefratelli
• RECRUITINGPHASE4NCT07136714
  Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
  Nordsjaellands Hospital

See all trials for Mal de débarquement →